Comparison of weight loss after Roux-en-Y gastric bypass in Helicobacter pylori-negative and Helicobacter pylori eradicated patients during five years follow-ups.
Bariatric surgery
Gastric bypass
Helicobacter pylori
RYGB
Weight loss
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
11 Dec 2023
11 Dec 2023
Historique:
received:
29
09
2023
accepted:
04
11
2023
medline:
12
12
2023
pubmed:
12
12
2023
entrez:
11
12
2023
Statut:
aheadofprint
Résumé
Helicobacter pylori (HP) is the most common human infection that has affected up to 50% of the population worldwide. The relationship between HP eradication and weight loss is under debate. The present study aimed to compare weight loss outcomes after Roux-en-Y gastric bypass (RYGB) in HP-negative (HP-) and HP-eradicated (HPe) patients during five years follow-ups. This retrospective cohort study was conducted on 305 patients aged 18 and more with severe obesity, who underwent primary RYGB from February 2014 to November 2017. The HP-negative and HP-eradicated patients were evaluated for weight loss outcomes during five years follow-ups. Patients' mean age, mean weight, and mean body mass index were 38.78 ± 9.9, 114.8 ± 13.6, and 43.37 ± 2.55, respectively. 27.2% of patients who were HP-positive were treated before RYGB. There was no significant difference between the HP- and HPe patients in terms of total weight loss percent (%TWL), 12 to 60 months after RYGB. Excess weight loss percent (%EWL) was higher in HPe patients compared to HP- patients (P = 0.04) at 12-month after RYGB. However, there was no difference in %EWL between these two groups of patients, 36 and 60 months after RYGB. The results of the present study showed that TWL% had no significant difference in HP- and HPe groups during five years follow-ups after RYGB. The %EWL was higher in HPe patients only at 12 months after RYGB and the difference did not persist over time.
Identifiants
pubmed: 38082012
doi: 10.1007/s00464-023-10578-w
pii: 10.1007/s00464-023-10578-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22(2):283–297
doi: 10.1093/oxfordjournals.epirev.a018040
pubmed: 11218379
Mocanu V, Dang JT, Switzer N, Skubleny D, Shi X, de Gara C et al (2018) The effect of Helicobacter pylori on postoperative outcomes in patients undergoing bariatric surgery: a systematic review and meta-analysis. Obes Surg 28:567–573
doi: 10.1007/s11695-017-3024-8
pubmed: 29159552
Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F et al (2012) Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report. Gut 61(5):646–664
doi: 10.1136/gutjnl-2012-302084
pubmed: 22491499
Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G (2014) Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol 20(36):12847
doi: 10.3748/wjg.v20.i36.12847
pubmed: 25278682
pmcid: 4177467
Wang Y-K, Kuo F-C, Liu C-J, Wu M-C, Shih H-Y, Wang SS et al (2015) Diagnosis of Helicobacter pylori infection: current options and developments. World J Gastroenterol 21(40):11221
doi: 10.3748/wjg.v21.i40.11221
pubmed: 26523098
pmcid: 4616200
Testerman TL, Morris J (2014) Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol 20(36):12781
doi: 10.3748/wjg.v20.i36.12781
pubmed: 25278678
pmcid: 4177463
Chiappetta S, Stier C, Ghanem OM, Dayyeh BKA, Boškoski I, Prager G et al (2023) Perioperative interventions to prevent gastroesophageal reflux disease and marginal ulcers after bariatric surgery - an international experts’ survey. Obes Surg 33(5):1449–1462
doi: 10.1007/s11695-023-06481-x
pubmed: 36781593
Kelly JJ, Perugini RA, Wang QL, Czerniach DR, Flahive J, Cohen PA (2015) The presence of Helicobacter pylori is not associated with long-term anastomotic complications in gastric bypass patients. Surg Endosc 29:2885–2890
doi: 10.1007/s00464-014-4022-8
pubmed: 25552229
Zanotti D, Elkalaawy M, Hashemi M, Jenkinson A, Adamo M (2016) Current status of preoperative oesophago-gastro-duodenoscopy (OGD) in bariatric NHS units—a BOMSS survey. Obes Surg 26:2257–2262
doi: 10.1007/s11695-016-2304-z
pubmed: 27424002
Iwańczak F, Iwańczak B (2012) Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance. Adv Clin Exp Med 21(5):671–680
pubmed: 23356205
Monno R, De Laurentiis V, Trerotoli P, Roselli AM, Ierardi E, Portincasa P (2019) Helicobacter pylori infection: association with dietary habits and socioeconomic conditions. Clin Res Hepatol Gastroenterol 43(5):603–607
doi: 10.1016/j.clinre.2018.10.002
pubmed: 30905666
Baradaran A, Dehghanbanadaki H, Naderpour S, Pirkashani LM, Rajabi A, Rashti R et al (2021) The association between Helicobacter pylori and obesity: a systematic review and meta-analysis of case–control studies. Clin Diabet Endocrinol 7(1):1–11
Hegde V, Dhurandhar N (2013) Microbes and obesity—interrelationship between infection, adipose tissue and the immune system. Clin Microbiol Infect 19(4):314–320
doi: 10.1111/1469-0691.12157
pubmed: 23506525
Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N et al (2009) Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14(5):496–502
doi: 10.1111/j.1523-5378.2009.00705.x
Erim T, Cruz-Correa MR, Szomstein S, Velis E, Rosenthal R (2008) Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg 32:2021–2025
doi: 10.1007/s00268-008-9608-7
pubmed: 18581170
Carabotti M, D’Ercole C, Iossa A, Corazziari E, Silecchia G, Severi C (2014) Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol 20(3):647
doi: 10.3748/wjg.v20.i3.647
pubmed: 24574738
pmcid: 3921474
Maksud FA, Alves JS, Diniz MT, Barbosa AJ (2011) Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients. Eur J Endocrinol 165(1):57–62
doi: 10.1530/EJE-11-0201
pubmed: 21558140
Arslan E, Atılgan H, Yavaşoğlu İ (2009) The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 20(7):695–697
doi: 10.1016/j.ejim.2009.07.013
pubmed: 19818289
Xu M-Y, Liu L, Yuan B-S, Yin J, Lu Q-B (2017) Association of obesity with Helicobacter pylori infection: a retrospective study. World J Gastroenterol 23(15):2750
doi: 10.3748/wjg.v23.i15.2750
pubmed: 28487612
pmcid: 5403754
Kermansaravi M, Shahmiri SS, Khalaj A, Jalali SM, Amini M, Alamdari NM et al (2022) The first web-based Iranian National Obesity and Metabolic Surgery Database (INOSD). Obes Surg 32(6):2083–2086
doi: 10.1007/s11695-022-06014-y
pubmed: 35303260
Pazouki A, Kermansaravi M (2019) Single Anastomosis Sleeve-Jejunal Bypass: a new method of bariatric/metabolic surgery. Obes Surg 29(11):3769–3770
doi: 10.1007/s11695-019-04016-x
pubmed: 31254211
Kermansaravi M, Parmar C, Chiappetta S, Shikora S, Aminian A, Abbas SI et al (2023) Best practice approach for redo-surgeries after sleeve gastrectomy, an expert’s modified Delphi consensus. Surg Endosc 37(3):1617–1628
doi: 10.1007/s00464-023-09879-x
pubmed: 36693918
Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D et al (2017) Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153(2):420–429
doi: 10.1053/j.gastro.2017.04.022
pubmed: 28456631
Wu M-S, Lee W-J, Wang H-H, Huang S-P, Lin J-T (2005) A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 165(13):1552–1555
doi: 10.1001/archinte.165.13.1552
pubmed: 16009873
Nwokolo C, Freshwater D, O’hare P, Randeva H (2003) Plasma ghrelin following cure of Helicobacter pylori. Gut 52(5):637–640
doi: 10.1136/gut.52.5.637
pubmed: 12692045
pmcid: 1773634
Carabotti M, D’Ercole C, Iossa A, Corazziari E, Silecchia G, Severi C (2014) Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol 20(3):647–653
doi: 10.3748/wjg.v20.i3.647
pubmed: 24574738
pmcid: 3921474
Smelt HJM, Smulders JF, Gilissen LPL, Said M, Ugale S, Pouwels S (2018) Influence of Helicobacter pylori infection on gastrointestinal symptoms and complications in bariatric surgery patients: a review and meta-analysis. Surg Obes Relat Dis 14(10):1645–1657
doi: 10.1016/j.soard.2018.06.020
pubmed: 30172695
Goday A, Castañer O, Benaiges D, Pou AB, Ramón JM, Iglesias MdM, et al (2018) Can Helicobacter pylori eradication treatment modify the metabolic response to bariatric surgery? Obes Surg 28:2386–95
Shanti H, Almajali N, Al-Shamaileh T, Samarah W, Mismar A, Obeidat F (2017) Helicobacter pylori does not affect postoperative outcomes after sleeve gastrectomy. Obes Surg 27:1298–1301
doi: 10.1007/s11695-016-2470-z
pubmed: 27878753
Gomberawalla A, Lutfi R (2015) Early outcomes of helicobacter pylori and its treatment after laparoscopic sleeve gastrectomy. Bariatr Surg Pract Patient Care 10(1):12–14
doi: 10.1089/bari.2014.0011
Brownlee AR, Bromberg E, Roslin MS (2015) Outcomes in patients with Helicobacter pylori undergoing laparoscopic sleeve gastrectomy. Obes Surg 25:2276–2279
doi: 10.1007/s11695-015-1687-6
pubmed: 26001881
Emile SH, Elshobaky A, Elbanna HG, Elkashef W, Abdel-Razik MA (2020) Helicobacter pylori, sleeve gastrectomy, and gastroesophageal reflux disease; is there a relation? Obes Surg 30(8):3037–3045
doi: 10.1007/s11695-020-04648-4
pubmed: 32358686